NMP Question Set 14 (Pharmacology)

Return to
Course Curriculum
1. What best defines therapeutic drug monitoring? *
2. Which statement accurately describes volume of distribution? *
3. Which mechanism promotes drug elimination via kidneys? *
4. What is the principal advantage of subcutaneous over oral route? *
5. Which enzyme family is central to Phase I drug metabolism? *
6. Which term describes a drug with a steep dose-response curve? *
7. What effect does hepatic impairment have on drug clearance? *
8. Which condition increases the risk of drug accumulation? *
9. What defines partial agonist activity? *
10. Which describes an example of pharmacodynamic tolerance? *
11. What best defines peak plasma concentration (Cₘₐₓ)? *
12. Which drug interaction exemplifies enzyme inhibition? *
13. What does the term ‘efficacy’ refer to in pharmacology? *
14. Which describes a drug with low protein binding? *
15. What defines steady-state concentration? *
16. Which drug exemplifies a narrow therapeutic index? *
17. What parameter increases with enzyme induction? *
18. What determines a drug’s potency? *
19. Which describes zero-order elimination kinetics? *
20. What is bioequivalence? *